Chronic Liver Disease Foundation
The foundation's goal is to provide health professionals with the most current education and information on CLD.
Educational programs are designed so physicians, nurses, nurse practitioners, physician assistants, and pharmacists have information about the latest medical developments and their implications for patient management. Information is drawn from academia, medical societies, government health agencies, and the pharmaceutical industry, and is integrated into balanced, up-to-date educational programs and materials for health professionals.
The Chronic Liver Disease Foundation is a nonprofit 501(c)(3) educational organization dedicated to increasing awareness of the effect of chronic liver disease (CLD) in the United States. All grants awarded to CLDF are restricted to support our programs and are not used for salaries and general administrative expenses of the Chronic Liver Disease Foundation.
Better Understanding of PBC Patients Overall Liver Health and Managing Patients Holistically
Unable to Differentiate/Identify Between Slow & Fast Progressors - Need to Manage More Aggressively
Not Responding to UDCA in the First Few Months, Need to Move on to Second-Line Therapy
Need for Clinicians to Better Understand The "Area Under the Curve" in Non-Response to UDCA
PBC Progression and Benefits of Early Diagnosis
What is PBC?
PBC Case Presentation With Dr. Brown
Epidemiology and Risk Factors of PBC
Building a Sense of Urgency for PBC Patient Evaluation/Monitoring
Need for Earlier Evaluation of UDCA Response, Need for Earlier Consideration of Second-Line Therapy
Importance of Understanding Impact on Disease Outcomes: Progression to Fibrosis and Cirrhosis
Biomarkers Beyond ALP to Monitor for Measuring PBC UDCA Response to Therapy and Disease Progression
Major Advancements in MASH Management
Major Advancement in MASH Management
Major Advancements in MASH Management
Major Advancement in MASH Management
Major Advancements in MASH Management
Management of Lifestyle Modification
Third Step of Lifestyle Management
Approved Medication for MASH/NASH
Clinical Trials of New Medications
Types of Diet for the Treatment of MASLD
NITs to Identify High Risk MASH Patients
Health-Related Quality of Life and Emerging Therapies In PBC
CLDF KOL Conversations: MASLD Positioning New and Emerging Therapies
CLDF/GHAPP Podcast: Cirrhosis and Hepatic Encephalopathy
CLDF Conversations: Hepatic Encephalopathy & Cirrhosis
CLDF Conversations: New Therapies in Mash & Comprehensive Care